Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of the American College of Cardiology

• Publication date

  1998-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(98)00210-1PMID 9669258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A kinetic model of the circulatory regulation of tissue plasminogen activator during orthotopic liver transplantation

  2000cited by this paper
• Vasodilation in black Americans: Attenuated nitric oxide‐mediated responses

  1997cited by this paper
• Tissue Plasminogen Activator (t-PA) Is Targeted to the Regulated Secretory Pathway

  1997cited by this paper
• An in vivo Model for the Assessment of Acute Fibrinolytic Capacity of the Endothelium

  1997cited by this paper
• Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm.

  1997cited by this paper
• Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool.

  1995cited by this paper
• Attenuation of isoproterenol-mediated vasodilatation in blacks.

  1995cited by this paper
• Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension.

  1995cited by this paper
• The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine.

  1995cited by this paper
• In Vivo Release of Tissue-Type Plasminogen Activator across the Human Forearm during Mental Stress

  1994cited by this paper
• Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke.

  1994cited by this paper
• Release of Tissue-Type Plasminogen Activator in Response to Muscarinic Receptor Stimulation in Human Forearm

  1994cited by this paper
• Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study.

  1993cited by this paper
• Stimulation of Plasminogen Activator Inhibitor In Vivo by Infusion of Angiotensin II Evidence of a Potential Interaction Between the Renin‐Angiotensin System and Fibrinolytic Function

  1993cited by this paper
• Predictive Value of Tissue Plasminogen Activator Mass Concentration on Long‐term Mortalit in Patients With Coronary Artery Disease A 7‐Year Follow‐up

  1993cited by this paper
• A kinetic model of the circulatory regulation of tissue plasminogen activator during exercise, epinephrine infusion, and endurance training.

  1993cited by this paper
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction.

  1993cited by this paper
• β‐Adrenergic receptor—mediated release of norepinephrine in the human forearm

  1993cited by this paper
• Liver Blood Flow as a Major Determinant of the Clearance of Recombinant Human Tissue-Type Plasminogen Activator

  1992cited by this paper
• Endothelium‐Dependent Vasodilation Is Attenuated in Patients With Heart Failure

  1991cited by this paper
• Nitric oxide: physiology, pathophysiology, and pharmacology.

  1991cited by this paper
• Low sodium intake corrects abnormality in β‐receptor–mediated arterial vasodilation in patients with hypertension: Correlation with β‐receptor function in vitro

  1990cited by this paper
• Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension.

  1990cited by this paper
• Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.

  1990cited by this paper
• Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

  1990cited by this paper
• Low sodium intake corrects abnormality in beta-receptor-mediated arterial vasodilation in patients with hypertension: correlation with beta-receptor function in vitro.

  1990cited by this paper
• Different Tissue Plasminogen Activator Release in the Arm and Leg during Venous Occlusion Is Equalized after DDAVP Infusion

  1990cited by this paper
• Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells.

  1989cited by this paper
• Tissue-type plasminogen activator release in response to epinephrine in perfused rat hindlegs.

  1989cited by this paper
• Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

  1987cited by this paper
• Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.

  1984cited by this paper
• Perfused rat hindlegs. A model to study plasminogen activator release.

  1983cited by this paper
• Release of plasminogen activator by acetylcholine from the isolated perfused pig ear.

  1979cited by this paper
• The plasminogen activator and coagulation factor VIII responses to adrenaline, noradrenaline, isoprenaline and salbutamol in man

  1973cited by this paper
• Adrenergic Mechanisms in the Systemic Plasminogen Activator Response to Adrenaline in Man

  1970cited by this paper
• The measurement of volume changes in human limbs

  1953cited by this paper

• Cerebral Angiography and Neurobehavioral Patterns in a Non-human Primate Middle Cerebral Artery Occlusion Model

  2024cites this paper
• Blood tissue Plasminogen Activator (tPA) of liver origin contributes to neurovascular coupling involving brain endothelial N-Methyl-D-Aspartate (NMDA) receptors

  2023cites this paper
• Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi

  2021cites this paper
• Plasminogen Activators in Neurovascular and Neurodegenerative Disorders

  2021cites this paper
• Evidence for wall shear stress-dependent t-PA release in human conduit arteries: role of endothelial factors and impact of high blood pressure

  2020cites this paper
• Acute exercise-induced changes in hemostatic and fibrinolytic properties: analogies, similarities, and differences between normotensive subjects and patients with essential hypertension

  2019cites this paper
• Disturbed Laminar Blood Flow Causes Impaired Fibrinolysis and Endothelial Fibrin Deposition In Vivo

  2019cites this paper
• Anxiety-Related Bleeding and Thrombosis

  2018cites this paper
• Causes and Solutions of Endovascular Treatment Failure

  2017cites this paper
• The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients

  2017cites this paper
• Stent Retriever (Stentriever) Thrombectomy for Acute Ischemic Stroke

  2017cites this paper
• Role of Vascular Endothelium in Hypertension, Atherosclerosis and Peripheral Arterial Disease

  2016cites this paper
• Coronary Artery Disease Bradykinin Stimulates the Release of Tissue Plasminogen Activator in Human Coronary Circulation : Effects of Angiotensin-Converting Enzyme Inhibitors

  2016cites this paper
• Endothelial Function Potentiation of Bradykinin-Induced Tissue Plasminogen Activator Release by Angiotensin-Converting Enzyme Inhibition

  2016cites this paper
• Proteomics analysis of brain AVM endothelium post irradiation in pursuit of targets for AVM molecular therapy

  2016cites this paper
• Impact of β-Adrenoceptor Blockade on Systemic Inflammation and Coagulation Disturbances in Rats with Acute Traumatic Coagulopathy

  2015cites this paper
• Outcomes and prognostic factors after emergent carotid artery stenting for hyperacute stroke within 6 hours of symptom onset.

  2015cites this paper
• Histone Deacetylase Inhibition Enhances Tissue Plasminogen Activator Release Capacity in Atherosclerotic Man

  2015cites this paper
• Epigenetic influence on cardiovascular protective mechanisms in vivo: explorations of t-PA release and extracellular vesicle genetic content

  2015influential citation
• 4.17 – Biocompatible Coating

  2014cites this paper
• Endothelium-Derived Hyperpolarizing Factor Mediates Bradykinin-Stimulated Tissue Plasminogen Activator Release in Humans

  2014cites this paper
• Hemodynamic, hemostatic, and endothelial reactions to acute psychological stress in depressed patients following coronary angiography.

  2013cites this paper
• cells modulation by plasminogen activator inhibitor-1 in vascular endothelial Unique secretory dynamics of tissue plasminogen activator and its

  2013cites this paper
• in human endothelial cells both in vitro and in vivo Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies

  2013cites this paper
• Studies into the interaction between the plasminogen activating system and the blood-brain barrier

  2013cites this paper
• The role of leptin in endothelial dysfunction and cardiovascular disease

  2013cites this paper
• Painless Livedoid Vasculopathy in a Patient with G20210A Prothrombin Gene Mutation

  2012influential citation
• Different cardiac tissue plasminogen activator release patterns by local stimulation of the endothelium and sympathetic nerves in pigs

  2012cites this paper
• Incomplete mechanical recanalization of middle cerebral artery occlusions facilitates endogenous recanalization within 5 h

  2012cites this paper
• Hypothermia in cardiogenic shock reduces systemic t-PA release

  2011cites this paper
• Cardioprotective treatment strategies

  2011cites this paper
• Atorvastatin restores the balance between pro-inflammatory and anti-inflammatory mediators in rats with acute myocardial infarction.

  2010cites this paper
• Partial recanalization of concomitant internal carotid–middle cerebral arterial occlusions promotes distal recanalization of residual thrombus within 24 h

  2010cites this paper
• Diabetes and acute coronary syndrome.

  2010cites this paper
• Vascular regulation of endogenous fibrinolysis in man

  2009cites this paper
• Thrombotic and endothelial factors in the control of human vascular function

  2009cites this paper
• Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells.

  2009cites this paper
• Impaired myocardial t‐PA release in patients with coronary artery disease

  2008cites this paper
• Tissue-Type Plasminogen Activator Release in Healthy Subjects and Hypertensive Patients: Relationship With β-Adrenergic Receptors and the Nitric Oxide Pathway

  2008cites this paper
• Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.

  2008cites this paper
• Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells.

  2008cites this paper
• in porcine endotoxemia

  2007cites this paper
• Fibrinolytic markers and vasodilatory capacity following acute exercise among men of differing training status

  2007cites this paper
• Nitric Oxide Modulates Tissue Plasminogen Activator Release in Normotensive Subjects and Hypertensive Patients

  2007cites this paper
• Endothelial Fibrinolytic Capacity Predicts Future Adverse Cardiovascular Events in Patients With Coronary Heart Disease

  2007cites this paper
• Acute Effects of Glucocorticoids on Endothelial Fibrinolytic and Vasodilator Function in Humans

  2007cites this paper
• Acute tissue-type plasminogen activator release in human microvascular endothelial cells: the roles of Galphaq, PLC-beta, IP3 and 5,6-epoxyeicosatrienoic acid.

  2007cites this paper
• Formation of fibrin clots in the microcirculation during severe sepsis contributes to organ failure

  2007cites this paper
• Regional fluxes of tissue plasminogen activator in porcine endotoxemia

  2007cites this paper
• Acute tissue-type plasminogen activator release in human microvascular endothelial cells: The roles of Gαq, PLC-β, IP3 and 5,6-epoxyeicosatrienoic acid

  2007cites this paper
• Endogenous t-PA release and pharmacological thrombolysis - Experimental animal studies of the coronary circulation

  2006cites this paper
• Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients.

  2006cites this paper
• Endothelial function and endogenous fibrinolysis in inflammation and ischaemic heart disease

  2006cites this paper
• Identification of Myxomaviral Serpin Reactive Site Loop Sequences That Regulate Innate Immune Responses*

  2006cites this paper
• Pseudo-supraventricular tachycardia

  2006cites this paper
• Local fibrinolysis

  2005cites this paper
• Distribution of sympathetic tissue plasminogen activator (tPA) to a distant microvasculature

  2005cites this paper
• Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation.

  2005cites this paper
• Stimulated release of tissue plasminogen activator from artery wall sympathetic nerves: Implications for stress-associated wall damage

  2005cites this paper
• Stimulated Tissue Plasminogen Activator Release as a Marker of Endothelial Function in Humans

  2005cites this paper
• Monitoring of fibrinolysis parameters during myocardial revascularization according to type of procedure

  2005cites this paper
• Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease

  2005cites this paper
• Endothelial dysfunction: methods of assessment and application to hypertension.

  2004cites this paper
• Vitamin C Has No Effect on Endothelium-Dependent Vasomotion and Acute Endogenous Fibrinolysis in Healthy Smokers

  2004cites this paper
• Evidence of a net release of tissue-type plasminogen activator across the human cerebral vasculature

  2004cites this paper
• Cardiac Sympathetic Nerve Stimulation Triggers Coronary t-PA Release

  2003cites this paper
• Regionally differentiated fibrinolytic responses during volume‐resuscitated acute endotoxemia in pigs

  2003cites this paper
• Acute and chronic effects of oestrogen on endothelial tissue‐type plasminogen activator release in postmenopausal women

  2003cites this paper
• Reactive hyperemia and tissue-type plasminogen activator release in hypertensive men

  2003cites this paper
• Plasminogen activation at the cell surface.

  2003cites this paper
• Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans

  2003cites this paper
• Local tissue factor pathway inhibitor release in the human forearm

  2003cites this paper
• Preparations and Experimental Protocols Experiment I : Stimulation of Cardiac Sympathetic Nerves

  2003cites this paper
• Preserved endothelial vasomotion and fibrinolytic function in patients with acute stent thrombosis or in-stent restenosis.

  2003cites this paper
• The Encyclopedia of Arthritis

  2003cites this paper
• Bench-to-bedside review: β2-Agonists and the acute respiratory distress syndrome

  2003cites this paper
• Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo.

  2002cites this paper
• Smoking Impairs Bradykinin-Stimulated t-PA Release

  2002cites this paper
• In vivo release of tissue-type plasminogen activator antigen from the human brachial artery.

  2002cites this paper
• Coronary release of t-PA

  2002cites this paper
• Oral Presentations 462-537

  2002cites this paper
• The effect of external pneumatic compression on regional fibrinolysis in a prospective randomized trial.

  2002influential citation
• Valsartan improves fibrinolytic balance in atherosclerotic rabbits

  2002cites this paper
• Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension.

  2001cites this paper
• VASCULAR ENDOTHELIUM AS AN ENDOCRINE ORGAN

  2001cites this paper
• Extracellular Nucleotides ATP and UTP Induce a Marked Acute Release of Tissue-type Plasminogen Activator In Vivo in Man

  2001cites this paper
• Agents which Increase Synthesis and Release of Tissue-Type Plasminogen Activator

  2001cites this paper
• Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.

  2001cites this paper
• Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors.

  2001cites this paper
• Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease.

  2001cites this paper
• Functions of the healthy endothelium.

  2001cites this paper
• Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.

  2000cites this paper
• Surgical stress induces acute coronary release of tissue‐type plasminogen activator in the pig

  2000cites this paper
• A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension.

  2000cites this paper
• Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man.

  2000cites this paper
• Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo

  2000cites this paper
• Testing for endothelial dysfunction

  2000cites this paper
• Vasoactive substances in the interstitium of contracting skeletal muscle examined by microdialysis

  1999cites this paper
• Sympathectomy decreases and adrenergic stimulation increases the release of tissue plasminogen activator (t‐PA) from blood vessels: Functional evidence for a neurologic regulation of plasmin production within vessel walls and other tissue matrices

  1999cites this paper
• Endothelin-1 does not contribute to the release of tissue plasminogen activator in vivo in man

  1999cites this paper